Affiliation:
1. Department of Gynecology, Northwest Women’s and Children’s Hospital, Xi’an, 710000, Shaanxi Province, PR China
2. Master of Public Administration, University of Southampton, Southampton, SO17 1BJ, United Kingdom
3. Department of Gynecology, Baoji Stomatological Hospital, Baoji, 721006, Shaanxi, PR China
Abstract
This study aimed to compare the clinical efficacy of laparoscopic sacrocolpopexy (LSC) and laparoscopic pectopexy (LP) for the treatment of pelvic organ prolapse (POP) and to evaluate the antibacterial effect of nanosilver-coated urethral catheters. The clinical data of 112 patients
with POP, including 56 patients who underwent LP and 56 patients who underwent LSC, from March 1, 2019 to March 31, 2021 were retrospectively evaluated. All patients underwent routine catheterization with nanosilver-coated urethral catheters after surgery. The baseline data, intraoperative
and postoperative efficacy, serum inflammatory indexes and postoperative complications were compared. The surgery was successfully completed in both groups, and a total of 10 patients in both group underwent intraoperative repair of the anterior and posterior vaginal walls. The surgical duration
was significantly shorter and the intraoperative blood loss was significantly lower in the LP group than in the LSC group (P <0.05 for both). In both groups, the POP quantification stage, which was ≥I prior to surgery, was ≤I at six months after surgery. The PFIQ-7, PFDI-20
and PISQ-12 scores were significantly improved in both groups (P <0.05 for all), and the improvements were significantly better in the LP group than in the LSC group (P <0.01). During the 6-month follow-up period, no patient developed urinary tract infection. The levels
of postoperative serum inflammatory factors WBC, ESR and CRP were increased in the LSC group and higher than those in the LP group, highlighting the significant anti-infection effect of the nanosilver-coated catheter. Mesh exposure occurred in one patient in the LSC group. In the LSC group,
postoperative symptoms including abnormal defecation, lower abdominal pain/soreness, new stress urinary incontinence, and dyspareunia. In the LP group, abnormal defecation and lower abdominal pain were present in one patient each. The rate of postoperative complications was higher in the LSC
group than in the LP group. While both LSC and LP could restore pelvic floor anatomic structure and organ function in patients with POP, shorter surgical duration, less blood loss, and better therapeutic effect were observed in patients undergoing LP. Nanosilver-coated antibacterial catheters
exhibited good antibacterial effect in patients with routine catheterization after surgery. This study provides a new treatment plan for the treatment of pelvic organ prolapse, and also provides a new nursing method for postoperative urinary tract infection.
Publisher
American Scientific Publishers
Subject
General Materials Science
Reference30 articles.
1. Pelvic floor physical therapy in the treatment of pelvic floor dysfunction in women;Wallace;Current Opinion in Obstetrics and Gynecology,2019
2. Pelvic organ prolapse;Iglesia;American Family Physician,2017
3. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse;Weintraub;International Brazilian Journal of Urology,2020
4. Pelvic organ prolapse;Female Pelvic Medicine and Reconstructive Surgery,2019
5. Pelvic organ prolapse: Review of the aetiology, presentation, diagnosis and management;Machin;Menopause International,2011